Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

A Study to Evaluate the Efficacy and Safety of Faricimab (RO6867461) in Participants With Diabetic Macular Edema

ClinicalTrials.gov ID: NCT03622593

Public ClinicalTrials.gov record NCT03622593. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 17, 2026, 8:22 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase III, Multicenter, Randomized, Double-Masked, Active Comparator-Controlled Study to Evaluate the Efficacy and Safety of Faricimab (RO6867461) in Patients With Diabetic Macular Edema (RHINE)

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This study will evaluate the efficacy, safety, and pharmacokinetics of faricimab administered at 8-week intervals or as specified in the protocol following treatment initiation, compared with aflibercept once every 8 weeks (Q8W), in participants with diabetic macular edema (DME).

Study identification

NCT ID
NCT03622593
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Hoffmann-La Roche
Industry
Enrollment
951 participants

Conditions and interventions

Interventions

Drug · Procedure

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Oct 9, 2018 (Actual)
Primary completion
Oct 19, 2020 (Actual)
Completion
May 31, 2023 (Actual)
Last update posted
Jul 11, 2025

2018 – 2023

United States locations

U.S. sites
50
U.S. states
21
U.S. cities
47
Facility City State ZIP Site status
Associated Retina Consultants Phoenix Arizona 85020 —
Retinal Research Institute, LLC Phoenix Arizona 85053 —
Northwest Arkansas Retina Associates Springdale Arkansas 72764 —
California Retina Consultants Bakersfield California 93309 —
Retina-Vitreous Associates Medical Group Beverly Hills California 90211 —
The Retina Partners Encino California 91436 —
Retina Consultants of Orange County Fullerton California 92835 —
Northern California Retina Vitreous Associates Mountain View California 94040 —
Retinal Consultants Med Group Sacramento California 95825 —
California Retina Consultants Santa Barbara California 93103 —
California Retina Consultants Santa Maria California 93454 —
Bay Area Retina Associates Walnut Creek California 94598 —
University of Colorado Aurora Colorado 80045 —
Retina Consultants of Southern Colorado Springs Colorado 80909 —
Retina Group of New England Waterford Connecticut 06385 —
Retina Group of Florida Fort Lauderdale Florida 33308 —
National Ophthalmic Research Institute Fort Myers Florida 33912 —
Florida Eye Associates Melbourne Florida 32901 —
Bascom Palmer Eye Institute Palm Beach Gardens Florida 33418 —
Fort Lauderdale Eye Institute Plantation Florida 33324 —
Retina Vitreous Assoc of FL St. Petersburg Florida 33711 —
Southeast Retina Center Augusta Georgia 30909 —
University Retina and Macula Associates, PC Oak Forest Illinois 60452 —
Prairie Retina Center Springfield Illinois 62704 —
Retina Specialists Baltimore Maryland 21204 —
Tufts Medical Center Boston Massachusetts 02111 —
Associated Retinal Consultants Grand Rapids Michigan 49546 —
Vitreo-Retinal Associates Grand Rapids Michigan 49546 —
Retina Consultants of Nevada Las Vegas Nevada 89144 —
Envision Ocular, LLC Bloomfield New Jersey 07003 —
Long Is. Vitreoretinal Consult Hauppauge New York 11788 —
New York University New York New York 10017 —
Ophthalmic Cons of Long Island Oceanside New York 11572 —
Retina Assoc of Western NY Rochester New York 14620 —
University of Rochester Flaum Eye Institute Rochester New York 14642 —
The Retina Consultants Slingerlands New York 12159 —
Cleveland Clinic Foundation Cleveland Ohio 44195 —
Mid Atlantic Retina - Wills Eye Hospital Philadelphia Pennsylvania 19107 —
Retina Consultants Of Carolina Greenville South Carolina 29605 —
Charleston Neuroscience Inst Ladson South Carolina 29456 —
Palmetto Retina Center West Columbia South Carolina 29169 —
Southeastern Retina Associates Chattanooga Chattanooga Tennessee 37421 —
Southeastern Retina Associates Knoxville Tennessee 37922 —
Tennessee Retina PC Nashville Tennessee 37203 —
Austin Retina Associates Austin Texas 78705 —
Retina Consultants of Texas Bellaire Texas 77401 —
Retina Center of Texas Southlake Texas 76092 —
Univ of Virginia Ophthalmology Charlottesville Virginia 22903 —
Retina Institute of Virginia Richmond Virginia 23235 —
Pacific Northwest Retina Silverdale Washington 98383 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 138 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03622593, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 11, 2025 · Synced Oct 17, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT03622593 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →